Wells Fargo
BOLD

Wells Fargo’s Boundless Bio BOLD Stock Holding History

Wells Fargo’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,582
Closed -$2.61K – 7460
2025
Q2 		$2.61K Sell
2,582
-6,283
-71% -$8.35K ﹤0.01% 6181
2025
Q1 		$13.4K Buy
8,865
+197
+2% +$408 ﹤0.01% 5819
2024
Q4 		$25.1K Buy
8,668
+3,348
+63% +$9.76K ﹤0.01% 5702
2024
Q3 		$18.5K Buy
5,320
+3,003
+130% +$10.9K ﹤0.01% 5659
2024
Q2 		$8.97K Buy
+2,317
New +$22.1K ﹤0.01% 5775

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wells Fargo's BOLD Position: Q3 2025 in Review

Wells Fargo sold out of Boundless Bio (BOLD) in Q3 2025, closing a stake of 2,582 shares — an estimated $2.61K sold.

Wells Fargo first reported a position in BOLD in Q2 2024 and held it in 5 quarters. The position peaked at $25.1K in Q4 2024. 35 funds tracked by Wall St. Rank hold BOLD as of Q3 2025.

  • Wells Fargo reported no remaining Boundless Bio position as of Q3 2025 after selling out during the quarter.
  • Wells Fargo sold 2,582 Boundless Bio shares in Q3 2025, an estimated $2.61K.
  • Wells Fargo first reported a position in Boundless Bio in Q2 2024 and held it in 5 quarters.
  • Wells Fargo's Boundless Bio position peaked at $25.1K in Q4 2024.
  • 35 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.